Table of Content

PART A: GLOBAL MARKET PERSPECTIVE
1. INTRODUCTION

  • Cancer Type Outline
  • Non-Small Cell Lung Cancer (NSCLC) Therapeutics Defined
  • Non-Small Cell Lung Cancer (NSCLC) Therapeutic Cancer Types
    • Adenocarcinoma
    • Squamous cell carcinoma (SCC)
    • Large cell carcinoma
    • Other Cancers (Including Adenosquamous Carcinoma, and Sarcomatoid Carcinoma)
  • Non-Small Cell Lung Cancer (NSCLC) Therapeutic Therapy Types
    • Targeted Therapy
    • Immunotherapy
    • Chemotherapy
    • Radiation Therapy
    • Others (Surgery, Photodynamic Therapy (PDT), and Palliative Care)
  • Non-Small Cell Lung Cancer (NSCLC) Therapeutic End-Users
    • Hospitals
    • Specialty Clinics
    • Other End-Users (Cancer Research Centers, Ambulatory Surgical Centers (ASCs), and Homecare settings)

2. Key Market Trends
3. Key Global Players

  • AbbVie Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GSK plc
  • Johnson & Johnson Innovative Medicine
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.

4. Key Business Trends
5. Global Market Overview

  • Global Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
    • Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview for Cancer Type by Global Region
      • Adenocarcinoma
      • Squamous cell carcinoma (SCC)
      • Large cell carcinoma
      • Other Cancer Types
  • Global Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
    • Non-Small Cell Lung Cancer (NSCLC) Therapeutics Therapy Type Market Overview by Global Region
      • Targeted Therapy
      • Immunotherapy
      • Chemotherapy
      • Radiation Therapy
      • Others
  • Global Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
    • Non-Small Cell Lung Cancer (NSCLC) Therapeutics End-User Market Overview by Global Region
      • Hospitals
      • Specialty Clinics
      • Other End-Users

PART B: REGIONAL MARKET PERSPECTIVE
Global Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Geographic Region
REGIONAL MARKET OVERVIEW
6. North America

  • North American Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Geographic Region
  • North American Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
  • North American Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
  • North American Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
  • Country-wise Analysis of North American Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market
    • The United States
      • United States Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
      • United States Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
      • United States Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
    • Canada
      • Canadian Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
      • Canadian Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
      • Canadian Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
    • Mexico
      • Mexican Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
      • Mexican Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
      • Mexican Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User

7. Europe

  • European Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Geographic Region
  • European Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
  • European Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
  • European Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
  • Country-wise Analysis of European Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market
    • Germany
      • German Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
      • German Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
      • German Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
    • France
      • French Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
      • French Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
      • French Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
    • The United Kingdom
      • United Kingdom Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
      • United Kingdom Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
      • United Kingdom Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
    • Italy
      • Italian Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
      • Italian Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
      • Italian Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
    • Spain
      • Spanish Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
      • Spanish Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
      • Spanish Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
    • Rest of Europe
      • Rest of Europe Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
      • Rest of Europe Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
      • Rest of Europe Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User

8. Asia-Pacific

  • Asia-Pacific Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Geographic Region
  • Asia-Pacific Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
  • Asia-Pacific Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
  • Asia-Pacific Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
  • Country-wise Analysis of Asia-Pacific Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market
    • Japan
      • Japanese Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
      • Japanese Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
      • Japanese Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
    • China
      • Chinese Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
      • Chinese Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
      • Chinese Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
    • India
      • Indian Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
      • Indian Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
      • Indian Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
    • South Korea
      • South Korean Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
      • South Korean Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
      • South Korean Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
    • Rest of Asia-Pacific
      • Rest of Asia-Pacific Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
      • Rest of Asia-Pacific Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
      • Rest of Asia-Pacific Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User

9. South America

  • South American Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Geographic Region
  • South American Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
  • South American Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
  • South American Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
  • Country-wise Analysis of Asia-Pacific Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market
    • Brazil
      • Brazilian Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
      • Brazilian Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
      • Brazilian Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
    • Argentina
      • Argentine Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
      • Argentine Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
      • Argentine Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User
    • Rest of South America
      • Rest of South American Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
      • Rest of South American Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
      • Rest of South American Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User

10. Rest of World

  • Rest of World Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Cancer Type
  • Rest of World Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by Therapy Type
  • Rest of World Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Overview by End-User

PART C: GUIDE TO THE INDUSTRY
PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK